[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]methanone – (939981-39-2)

PPQ-102, 931706-15-9, PPQ 102, 7, 9-dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-5, 6-dihydropyrimido[4', 5':3, 4]pyrrolo[1, 2-a]quinoxaline-8, 10(7H, 9H)-dione, CHEMBL1087004, 7, 9-dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-6, 7-dihydropyrimido[4', 5':3, 4]pyrrolo[1, 2-a]quinoxaline-8, 10(5H, 9H)-dione, 7, 9-Dimethyl-6-(5-methyl-furan-2-yl)-11-phenyl-6, 7-dihydro-5H-5, 7, 9, 11a-tetraaza-benzo[a]fluorene-8, 10-dione, CFTR Inhibitor IV, MFCD14824240, 12, 14-Dimethyl-9-(5-methylfuran-2-yl)-17-phenyl-1, 8, 12, 14-tetrazatetracyclo[8.7.0.02, 7.011, 16]heptadeca-2, 4, 6, 10, 16-pentaene-13, 15-dione, PPQ102, SCHEMBL11907613, CFTR Inhibitor IV, PPQ-102, MNOOVRNGPIWJDI-UHFFFAOYSA-N, HMS1856O19, BCP09625, EX-A2141, GMB70615, PPQ-102?, BDBM50324734, CCG-80832, AKOS001913944, AKOS022056355, NCGC00119851-01, AC-35946, AS-55951, DA-40404, HY-14179, S0198, D359-0041, 12, 14-DIMETHYL-9-(5-METHYLFURAN-2-YL)-17-PHENYL-1, 8, 12, 14-TETRAAZATETRACYCLO[8.7.0.0(2), ?.0(1)(1), (1)?]HEPTADECA-2(7), 3, 5, 10, 16-PENTAENE-13, 15-DIONE, 12, 14-dimethyl-9-(5-methylfuran-2-yl)-17-phenyl-1, 8, 12, 14-tetraazatetracyclo[8.7.0.0(2), ?.0(1)(1), (1)?]heptadeca-2, 4, 6, 10, 16-pentaene-13, 15-dione, 6, 7-dihydro-7, 9-dimethyl-6-(5-methyl-2-furanyl)-11-phenyl-pyrimido[4', 5':3, 4]pyrrolo[1, 2-a]quinoxaline-8, 10(5H, 9)-dione, 7, 9-dimethyl-6-(5-methyl-2-furyl)-11-phenyl-6, 7-dihydropyrimido[4', 5':3, 4]pyrrolo[1, 2-a]quinoxaline-8, 10(5H, 9H)-dione